Drugs.com - Pharma Industry News

ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease

WEDNESDAY, April 2, 2025 -- For patients with symptomatic peripheral artery disease and type 2 diabetes, semaglutide use is associated with increased walking distance, according to a study published online March 29 in The Lancet to coincide with...

Apr 2, 2025 - 18:57
 0
ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
WEDNESDAY, April 2, 2025 -- For patients with symptomatic peripheral artery disease and type 2 diabetes, semaglutide use is associated with increased walking distance, according to a study published online March 29 in The Lancet to coincide with...
Read More

Tags:

Previous Article

ACC: 1999 to 2022 Saw Increase in Maternal Mortality Due to CVD

Next Article

AGA Finds No Clear Evidence for or Against AI-Assisted Colonoscopy

Related Posts

People With Disabilities Often Feel Disrespected by Health Care Workers

People With Disabilities Often Feel Disrespected by Hea...

Mar 10, 2025  0

Bladder Wall Thickness Reflects Severity of Bladder Inflammatory Conditions

Bladder Wall Thickness Reflects Severity of Bladder Inf...

Mar 7, 2025  0

Few Nonsurgical Treatments Show Effectiveness for Low Back Pain

Few Nonsurgical Treatments Show Effectiveness for Low B...

Mar 19, 2025  0